The National Health Service in England is facing a challenging spring, with key performance targets for reducing wait times in emergency care, cancer treatment, and routine hospital procedures increasingly unlikely to be met by the end of the fiscal year on March 31st. A recent analysis of NHS data reveals a persistent struggle to improve access to care, raising questions about the ambitious pledges made by the government to overhaul the system. This shortfall in progress impacts millions of patients already facing lengthy delays for essential medical attention.
The current situation casts a shadow over Health Secretary Wes Streeting’s commitment to significantly reduce waiting lists and improve performance across the board by 2029. While Streeting has repeatedly emphasized a turnaround is underway, the latest figures suggest the path to recovery will be steeper than anticipated. The Labour government, under Prime Minister Keir Starmer, inherited a system already strained by years of increasing demand and funding pressures, and their promise to “get the NHS back on its feet” is now being closely scrutinized.
Despite a recent £120 million injection of funds aimed at accelerating appointments and operations – dubbed an “elective sprint” – the NHS is falling short of several crucial benchmarks. One key target involves ensuring 92% of patients waiting for non-urgent hospital care receive treatment within 18 weeks. Yet, as of January, only 61.5% of patients were seen within that timeframe, a slight improvement from 58.9% the previous year, but still well below the 65% goal set for this fiscal year. Data shows that only 52 out of 150 NHS trusts – roughly one in three – achieved the 65% performance level in January.
Widespread Performance Shortfalls Across the System
The challenges extend beyond elective care. A significant 70% of NHS trusts – 112 in total – failed to meet the requirement of improving performance by at least 5% compared to the previous year, with 44 trusts actually experiencing a worsening of their 18-week wait times. This indicates systemic issues hindering consistent improvement across the country. The strain is particularly acute in diagnostic services, with waiting lists for tests reaching 1.8 million – the highest level since the COVID-19 pandemic. Delays in obtaining X-rays, scans, and other diagnostic procedures are directly contributing to the backlog in treatment, as these tests are often the crucial first step in a patient’s care pathway.
Magentus, a firm specializing in NHS diagnostics, reported that 139,652 people were waiting more than 13 weeks for a diagnostic test as of January 2024, exceeding the recommended six-week maximum. Marlen Suller, Magentus’s managing director for clinical diagnostics, explained that these delays “can mean worrying waits for many patients…and people who don’t necessitate further care can’t be discharged and safely moved off the waiting list.”
Emergency care is similarly under pressure. The NHS is projected to miss its target of treating 78% of A&E patients within four hours by the end of March. In February, the performance rate stood at 74.1%, falling short of the goal. Ambulance response times for category two calls – which include strokes and heart attacks – are also lagging, with an average response time of 30 minutes and 25 seconds in January, slightly above the 30-minute target. While six of England’s 11 ambulance trusts met the 30-minute target, five did not.
Political Fallout and Future Prospects
The missed targets have drawn criticism from opposition parties. Helen Morgan, the Liberal Democrats’ health spokesperson, stated that the failures “have very real human consequence” and will force patients to endure prolonged delays. She also accused the Labour government of failing to deliver on its promises to improve the NHS.
Despite the challenges, there are some areas of positive development. The NHS has reported an increase in patient satisfaction with GP appointments, a key priority for the government. Tim Gardner, assistant director of policy at the Health Foundation, acknowledged that “recent progress is encouraging,” but cautioned that achieving the government’s pledges will require “a herculean effort.” He also noted that projections from the Health Foundation suggest the Labour party may not be able to meet its 2029 target of ensuring 92% of patients receive elective hospital care within 18 weeks.
Speaking on the Guardian’s Politics Weekly podcast, Wes Streeting reiterated his commitment to achieving the 92% target, as well as improvements in A&E wait times, cancer treatment timelines, and ambulance response times. He highlighted that waiting lists have fallen by 374,000 since Labour took office in July 2024, and that public satisfaction with the NHS has seen a slight increase, albeit to 26%. However, Stuart Hoddinott, an associate director at the Institute for Government, pointed out that this progress was made from a “very low base” and that the upward trend in waiting times predates the current administration.
The NHS maintains that it is working diligently to address the challenges. An NHS spokesperson stated that recent data analysis is based on “traditional data” and that the service has made “dramatic improvements” since the end of January, bringing it “within a hare’s whisker of the 18-week target.” They also emphasized the record number of appointments, tests, and scans delivered in 2025, and the reduction in waiting lists to their lowest level in three years.
The coming weeks will be critical as the NHS strives to meet its end-of-year targets. The official figures for March will provide a clearer picture of the extent to which the service has been able to overcome the current obstacles. The next major update on NHS performance is expected in April, when the full-year data will be published by NHS England.
This represents a developing story. If you have been affected by NHS waiting times, share your experience in the comments below.
Disclaimer: This article provides information about healthcare and should not be considered medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
